Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS -1.85%·Rev n/aQ3 25EPS -11.11%·Rev n/aQ2 25EPS -10.00%·Rev n/aQ1 25EPS -5.96%·Rev n/a⚠ consensus missing

GoodRx Holdings, Inc. GDRX

Aubrey Reynolds — Director of Investor Relations

Wendy Barnes — Chief Executive Officer

Chris McGinnis — Chief Financial Officer

−18.8%1d on move date−18.2% vs SPY3d−11.4%5d−11.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GDRX calls or request research access.

More GDRX calls Browse calls Request research access